Squarepoint’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-18,179
| Closed | -$539K | – | 4785 |
|
|
2023
Q4 | $539K | Sell |
18,179
-317,911
| -95% | -$6.33M | ﹤0.01% | 2955 |
|
|
2023
Q3 | $5.33M | Buy |
336,090
+260,714
| +346% | +$4.34M | 0.01% | 1135 |
|
|
2023
Q2 | $1.42M | Buy |
+75,376
| New | +$890K | ﹤0.01% | 1910 |
|
|
2023
Q1 | – | Sell |
-243,195
| Closed | -$1.21M | – | 3961 |
|
|
2022
Q4 | $1.21M | Sell |
243,195
-106,815
| -31% | -$579K | ﹤0.01% | 1697 |
|
|
2022
Q3 | $1.67M | Buy |
350,010
+233,781
| +201% | +$1.23M | 0.01% | 1435 |
|
|
2022
Q2 | $523K | Sell |
116,229
-140,721
| -55% | -$611K | ﹤0.01% | 1992 |
|
|
2022
Q1 | $1.22M | Buy |
256,950
+195,742
| +320% | +$1.08M | 0.01% | 1462 |
|
|
2021
Q4 | $454K | Sell |
61,208
-6,386
| -9% | -$39.7K | ﹤0.01% | 2198 |
|
|
2021
Q3 | $383K | Sell |
67,594
-50,876
| -43% | -$294K | ﹤0.01% | 2118 |
|
|
2021
Q2 | $781K | Sell |
118,470
-155,056
| -57% | -$1.08M | ﹤0.01% | 1816 |
|
|
2021
Q1 | $2.22M | Buy |
273,526
+61,338
| +29% | +$501K | 0.01% | 1009 |
|
|
2020
Q4 | $1.37M | Buy |
212,188
+115,405
| +119% | +$673K | 0.01% | 1147 |
|
|
2020
Q3 | $348K | Buy |
96,783
+62,475
| +182% | +$252K | ﹤0.01% | 1696 |
|
|
2020
Q2 | $158K | Sell |
34,308
-8,610
| -20% | -$36.6K | ﹤0.01% | 1899 |
|
|
2020
Q1 | $146K | Sell |
42,918
-242,637
| -85% | -$1.06M | ﹤0.01% | 1563 |
|
|
2019
Q4 | $1.46M | Sell |
285,555
-316,271
| -53% | -$1.07M | 0.01% | 1092 |
|
|
2019
Q3 | $1.46M | Buy |
601,826
+559,035
| +1,306% | +$1.48M | 0.01% | 987 |
|
|
2019
Q2 | $93K | Sell |
42,791
-259,390
| -86% | -$613K | ﹤0.01% | 2236 |
|
|
2019
Q1 | $819K | Buy |
302,181
+13,125
| +5% | +$56.9K | 0.01% | 1198 |
|
|
2018
Q4 | $1.39M | Buy |
289,056
+199,356
| +222% | +$1.21M | 0.02% | 808 |
|
|
2018
Q3 | $849K | Sell |
89,700
-1,100
| -1% | -$10.6K | 0.01% | 1070 |
|
|
2018
Q2 | $883K | Buy |
90,800
+49,600
| +120% | +$523K | 0.01% | 938 |
|
|
2018
Q1 | $433K | Buy |
+41,200
| New | +$407K | 0.01% | 1146 |
|
|
2017
Q1 | – | Sell |
-75,083
| Closed | -$153K | – | 1986 |
|
|
2016
Q4 | $153K | Buy |
+75,083
| New | +$151K | 0.01% | 1536 |
|
|
2016
Q1 | – | Sell |
-24,100
| Closed | -$327K | – | 1506 |
|
|
2015
Q4 | $327K | Buy |
+24,100
| New | +$297K | 0.04% | 760 |
|
Other funds holding IMGN
Squarepoint's IMGN Position: Q1 2024 in Review
Squarepoint sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 18,179 shares — an estimated $539K sold.
Squarepoint first reported a position in IMGN in Q4 2015 and held it in 25 quarters. The position peaked at $5.33M in Q3 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Squarepoint reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Squarepoint sold 18,179 Immunogen Inc shares in Q1 2024, an estimated $539K.
- Squarepoint first reported a position in Immunogen Inc in Q4 2015 and held it in 25 quarters.
- Squarepoint's Immunogen Inc position peaked at $5.33M in Q3 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Squarepoint's 13F filing for Q1 2024, filed 15 May 2024.